Slope is a global provider of biospecimen lifecycle software, data, and services for complex clinical trials

all companies
milestones

Founded 2016

Partnered 2024

Team

Rust Felix

Board

Omair Khan

LEAD INVESTOR
category
Multi + Other

Slope ensures that the full potential of every sample is realized, unlocking the ability for biospecimens to fuel groundbreaking discoveries. When you partner with Slope, your biospecimens don’t just support research — they pave the way for scientific advancements that can save and improve lives.

No items found.